VistaGen Therapeutics, Inc. (VTGN) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 465K | 303K | 258K | 244K | -15K | 234K | 183K | 84K | 197.3K | 411.4K | 278K | 177K |
| Revenue Growth % | 3200% | 29.49% | 40.98% | 190.48% | -107.6% | -43.12% | -34.17% | -52.54% | 12.36% | 129.06% | 131.15% | -42.92% |
| Cost of Goods Sold | 0 | 189K | 0 | 169K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | 62.38% | - | 69.26% | - | - | - | - | - | - | - | - |
| Gross Profit | 465K | 114K | 258K | 75K | -15K | 234K | 183K | 84K | 197.3K | 411.4K | 278K | 177K |
| Gross Margin % | 100% | 37.62% | 100% | 30.74% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | 3200% | -51.28% | 40.98% | -10.71% | -107.6% | -43.12% | -34.17% | -52.54% | 12.36% | 129.06% | 131.15% | -42.92% |
| Operating Expenses | 17.18M | 19.66M | 20.31M | 15.88M | 14.48M | 15.35M | 14.41M | 12.21M | 11.56M | 8.3M | 7.06M | 7.17M |
| OpEx % of Revenue | 3695.05% | 6488.45% | 7872.48% | 6507.79% | -96533.33% | 6561.54% | 7874.32% | 14541.67% | 5857.22% | 2016.38% | 2538.85% | 4053.67% |
| Selling, General & Admin | 4.12M | 5.49M | 4.4M | 4.37M | 4.27M | 4.05M | 4.2M | 4.57M | 4.12M | 3.76M | 3.21M | 2.98M |
| SG&A % of Revenue | 886.45% | 1812.21% | 1703.88% | 1790.98% | -28486.67% | 1730.34% | 2292.35% | 5436.9% | 2088.19% | 913.47% | 1153.6% | 1682.49% |
| Research & Development | 13.06M | 14.17M | 15.91M | 11.68M | 10.21M | 11.3M | 10.21M | 7.65M | 7.44M | 4.54M | 3.85M | 4.2M |
| R&D % of Revenue | 2808.6% | 4676.24% | 6168.6% | 4786.07% | -68046.67% | 4831.2% | 5581.97% | 9104.76% | 3769.18% | 1102.97% | 1385.25% | 2371.19% |
| Other Operating Expenses | 0 | 0 | 0 | -169K | 0 | 0 | 0 | 0 | -300 | -200 | 0 | 0 |
| Operating Income | -16.72M | -19.55M | -20.05M | -15.8M | -14.49M | -15.12M | -14.23M | -12.13M | -11.36M | -7.88M | -6.78M | -7M |
| Operating Margin % | -3595.05% | -6450.83% | -7772.48% | -6477.05% | 96633.33% | -6461.54% | -7774.32% | -14441.67% | -5757.22% | -1916.38% | -2438.85% | -3953.67% |
| Operating Income Growth % | -15.33% | -29.27% | -40.95% | -30.28% | -27.61% | -91.78% | -109.84% | -73.35% | 7.19% | 19.28% | 61.23% | 64.61% |
| EBITDA | -16.53M | -19.36M | -19.87M | -15.63M | -14.33M | -14.96M | -14.07M | -11.98M | -11.21M | -7.74M | -6.64M | -6.86M |
| EBITDA Margin % | -3554.19% | -6388.45% | -7700.78% | -6407.79% | 95526.67% | -6392.73% | -7688.52% | -14261.9% | -5682.97% | -1881.5% | -2388.85% | -3875.14% |
| EBITDA Growth % | -15.34% | -29.4% | -41.21% | -30.51% | -27.79% | -93.26% | -111.87% | -74.66% | 7.35% | 19.66% | 61.74% | 65.08% |
| D&A (Non-Cash Add-back) | 190K | 189K | 185K | 169K | 166K | 161K | 157K | 151K | 146.5K | 143.5K | 139K | 139K |
| EBIT | -16.72M | -18.9M | -19.42M | -15.1M | -13.63M | -14.09M | -12.95M | -10.73M | -11.36M | -7.88M | -6.59M | -6.89M |
| Net Interest Income | 452K | 647K | 630K | 711K | 855K | 1.03M | 1.27M | 1.4M | 1.53M | 1.53M | 192K | 97.2K |
| Interest Income | 452K | 647K | 630K | 711K | 855K | 1.03M | 1.27M | 1.4M | 1.53M | 1.53M | 192K | 103.2K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6K |
| Other Income/Expense | 450K | 647K | 636K | 709K | 860K | 1.03M | 1.27M | 1.4M | 1.84M | 1.53M | 192K | 98K |
| Pretax Income | -16.27M | -18.9M | -19.42M | -15.1M | -13.63M | -14.09M | -12.95M | -10.73M | -9.52M | -6.35M | -6.59M | -6.9M |
| Pretax Margin % | -3498.28% | -6237.29% | -7525.97% | -6186.48% | 90900% | -6020.94% | -7078.69% | -12777.38% | -4825.09% | -1543.46% | -2369.78% | -3898.31% |
| Income Tax | 7K | 0 | 0 | 0 | 0 | 0 | 7K | 0 | 1.5K | 0 | 0 | 3K |
| Effective Tax Rate % | -0.04% | 0% | 0% | 0% | 0% | 0% | -0.05% | 0% | -0.02% | 0% | 0% | -0.04% |
| Net Income | -16.27M | -18.9M | -19.42M | -15.1M | -13.63M | -14.09M | -12.96M | -10.73M | -9.52M | -6.35M | -6.59M | -6.9M |
| Net Margin % | -3499.78% | -6237.29% | -7525.97% | -6186.48% | 90900% | -6020.94% | -7082.51% | -12777.38% | -4825.85% | -1543.46% | -2369.78% | -3900% |
| Net Income Growth % | -19.35% | -34.14% | -49.81% | -40.64% | -43.2% | -121.88% | -96.74% | -55.48% | 22.13% | 34.95% | 62.32% | 65.09% |
| Net Income (Continuing) | -16.27M | -18.9M | -19.42M | -15.1M | -13.63M | -14.09M | -12.96M | -10.73M | -9.52M | -6.35M | -6.59M | -6.9M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.41 | -0.45 | -0.54 | -0.47 | -0.44 | -0.46 | -0.42 | -0.35 | -0.35 | -0.43 | -0.66 | -0.94 |
| EPS Growth % | 6.82% | 2.17% | -28.57% | -34.29% | -25.71% | -6.98% | 36.36% | 62.77% | 79.53% | 69.72% | 74.02% | 67.25% |
| EPS (Basic) | -0.41 | -0.45 | -0.54 | -0.47 | -0.44 | -0.46 | -0.42 | -0.35 | -0.35 | -0.43 | -0.66 | -0.94 |
| Diluted Shares Outstanding | 38.07M | 42.23M | 35.75M | 31.93M | 30.71M | 30.71M | 30.63M | 30.6M | 27.03M | 14.7M | 10.04M | 7.38M |
| Basic Shares Outstanding | 38.07M | 42.23M | 35.75M | 31.93M | 30.71M | 30.71M | 30.63M | 30.6M | 27.03M | 14.7M | 10.04M | 7.38M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |